{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:54:14Z","timestamp":1771462454101,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00001"],"award-info":[{"award-number":["75N92021D00001"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00002"],"award-info":[{"award-number":["75N92021D00002"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00003"],"award-info":[{"award-number":["75N92021D00003"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00004"],"award-info":[{"award-number":["75N92021D00004"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92021D00005"],"award-info":[{"award-number":["75N92021D00005"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Health and Human Services\/National Institutes of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Interleukin-6 (IL-6) levels have been related to increased risk of chronic disease and mortality. Whether genetic IL-6 receptor (IL6R) blockade is associated with lower chronic disease risk or greater longevity is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The analytic cohort consisted of 38 807 Women\u2019s Health Initiative participants who had available genotyping information, of which 23 464 were eligible to survive to 90 years of age through February 192 023. Carrier status of the IL6R variant (rs8192284; p.Asp358Ala) was determined via genotyping. Chronic-disease outcome data were available through 19 February 2023 for coronary heart disease (CHD), heart failure (HF), stroke, and invasive cancer events. Prospective associations of IL6R carrier status with chronic-disease outcomes were assessed with the Cox proportional hazards models, and logistic regression was used to evaluate survival to 90 years of age during follow-up. During a median follow-up of 20 years, 12 181 of 23 464 women (52.0%) survived to age 90. No significant difference in the likelihood of surviving to age 90 was detected between women with 2 alleles of the IL6R gene variant compared to women without any allele (Odds Ratio, 1.00; 95% confidence interval, 0.91\u20131.09). The risks of CHD, HF, stroke, or cancer did not differ among IL6R variant carriers. High-sensitive C-reactive Protein (hsCRP) levels \u22652\u2005mg\/L compared to &amp;lt;2\u2005mg\/L were associated with a modest increase in all-cause mortality and CHD risk, independent of IL6R allele carrier status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Genetic IL6R blockade was not associated with incident chronic-disease risk, including invasive cancer and longevity, in a large, ethnically diverse cohort of postmenopausal women. No significant interaction with hsCRP levels was observed. While pharmacological blockade of IL6R has become a major therapeutic strategy in the treatment of immune-mediated inflammatory disease, these long-term data on genetic IL6R blockade do not indicate an altered likelihood for survival to very old age.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf444","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T10:12:56Z","timestamp":1752747176000},"page":"381-390","source":"Crossref","is-referenced-by-count":1,"title":["Genetic interleukin-6 receptor blockade, chronic disease risk, and longevity: results from the women\u2019s health initiative"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1625-6956","authenticated-orcid":false,"given":"Stephanie","family":"Wissel","sequence":"first","affiliation":[{"name":"Department of Medicine I, University of W\u00fcrzburg , Bavaria ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M","family":"Hovey","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo\u2014SUNY , Buffalo, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris A","family":"Andrews","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo\u2014SUNY , Buffalo, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor R","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo\u2014SUNY , Buffalo, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aladdin H","family":"Shadyab","sequence":"additional","affiliation":[{"name":"Herbert Wertheim School of Public Health and Human Longevity Science and Division of Geriatrics, Gerontology, and Palliative Care, Department of Medicine, University of California San Diego , La Jolla, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B","family":"Wallace","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology & Medicine, University of Iowa , Iowa City, IA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Yon","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Fielding School of Public Health, Translational Sciences Section, School of Nursing, Jonsson Comprehensive Cancer Center, University of California Lost Angeles , Los Angeles, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Nassir","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Umm Al-Qura University , Mecca ,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Eaton","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Epidemiology, Brown University , Providence, RI ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-6996","authenticated-orcid":false,"given":"Marcia L","family":"Stefanick","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University Medical Center Palo Alto CA. Departments of Obstetrics and Gynecology, Stanford University , Palo Alto, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"LaCroix","sequence":"additional","affiliation":[{"name":"Herbert Wertheim School of Public Health and Human Longevity Science and Division of Geriatrics, Gerontology, and Palliative Care, Department of Medicine, University of California San Diego , La Jolla, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9426-7595","authenticated-orcid":false,"given":"JoAnn E","family":"Manson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Wassertheil-Smoller","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Population Health, Albert Einstein College of Medicine , Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, Bronx, NY 10461 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"LaMonte","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo\u2014SUNY , Buffalo, NY ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6109-431X","authenticated-orcid":false,"given":"Bernhard","family":"Haring","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Population Health, Albert Einstein College of Medicine , Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, Bronx, NY 10461 ,","place":["USA"]},{"name":"Department of Medicine III, Saarland University Hospital , Kirrberger Stra\u00dfe 100, 66421 Homburg, Saarland ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"2026021723130391000_zwaf444-B1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jchf.2023.06.031","article-title":"Interleukin-6 in patients with heart failure and preserved ejection fraction","volume":"11","author":"Alogna","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2026021723130391000_zwaf444-B2","first-page":"1","article-title":"Biomarkers of dysfunctional visceral fat","volume":"109","author":"Gugliucci","year":"2022","journal-title":"Adv Clin Chem"},{"key":"2026021723130391000_zwaf444-B3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/eurjpc\/zwad197","article-title":"Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: atherosclerosis risk in communities study","volume":"30","author":"Jia","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2026021723130391000_zwaf444-B4","doi-asserted-by":"crossref","first-page":"101063","DOI":"10.1016\/j.jacadv.2024.101063","article-title":"Interleukin-6 and cardiovascular events in healthy adults: MESA","volume":"3","author":"Khan","year":"2024","journal-title":"JACC Adv"},{"key":"2026021723130391000_zwaf444-B5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2026021723130391000_zwaf444-B6","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"2026021723130391000_zwaf444-B7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026021723130391000_zwaf444-B8","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1093\/cvr\/cvab231","article-title":"From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?","volume":"117","author":"Ridker","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2026021723130391000_zwaf444-B9","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"2026021723130391000_zwaf444-B10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"IL6R Genetics Consortium Emerging Risk Factors Collaboration","year":"2012","journal-title":"Lancet"},{"key":"2026021723130391000_zwaf444-B11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis","volume":"379","author":"Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium","year":"2012","journal-title":"Lancet"},{"key":"2026021723130391000_zwaf444-B12","doi-asserted-by":"crossref","first-page":"e002872","DOI":"10.1161\/CIRCGEN.119.002872","article-title":"Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian randomization study","volume":"13","author":"Georgakis","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2026021723130391000_zwaf444-B13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"2026021723130391000_zwaf444-B14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the women's health initiative clinical trial and observational study","volume":"19","author":"Group. WsHIS","year":"1998","journal-title":"Control Clin Trials"},{"key":"2026021723130391000_zwaf444-B15","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","article-title":"Implementation of the women's health initiative study design","volume":"13","author":"Anderson","year":"2003","journal-title":"Ann Epidemiol"},{"key":"2026021723130391000_zwaf444-B16","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","article-title":"Outcomes ascertainment and adjudication methods in the women's health initiative","volume":"13","author":"Curb","year":"2003","journal-title":"Ann Epidemiol"},{"key":"2026021723130391000_zwaf444-B17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women\u2019s Health Initiative Clinical Trial and Observational Study. The Women's Health Initiative Study Group","volume":"19","year":"1998","journal-title":"Control Clin Trials"},{"key":"2026021723130391000_zwaf444-B18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/HYPERTENSIONAHA.107.103721","article-title":"Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women","volume":"51","author":"Wassertheil-Smoller","year":"2008","journal-title":"Hypertension"},{"key":"2026021723130391000_zwaf444-B19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.04.006","article-title":"Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the women's health initiative observational study","volume":"17","author":"Kaplan","year":"2008","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026021723130391000_zwaf444-B20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/STROKEAHA.111.641324","article-title":"Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women","volume":"43","author":"Berger","year":"2012","journal-title":"Stroke"},{"key":"2026021723130391000_zwaf444-B21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.breast.2018.03.013","article-title":"Social relationships, inflammation markers, and breast cancer incidence in the women's health initiative","volume":"39","author":"Busch","year":"2018","journal-title":"Breast"},{"key":"2026021723130391000_zwaf444-B22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1373\/clinchem.2010.156794","article-title":"Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women","volume":"57","author":"Wang","year":"2011","journal-title":"Clin Chem"},{"key":"2026021723130391000_zwaf444-B23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/heartjnl-2015-308927","article-title":"The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women","volume":"102","author":"Ermakov","year":"2016","journal-title":"Heart"},{"key":"2026021723130391000_zwaf444-B24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2023.01.010","article-title":"Evaluation of the association between circulating IL-1\u03b2 and other inflammatory cytokines and incident atrial fibrillation in a cohort of postmenopausal women","volume":"258","author":"Gomez","year":"2023","journal-title":"Am Heart J"},{"key":"2026021723130391000_zwaf444-B25","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1001\/archinte.167.15.1676","article-title":"A prospective study of inflammatory cytokines and diabetes Mellitus in a multiethnic cohort of postmenopausal women","volume":"167","author":"Liu","year":"2007","journal-title":"Arch Intern Med"},{"key":"2026021723130391000_zwaf444-B26","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2337\/db07-0250","article-title":"Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women","volume":"56","author":"Song","year":"2007","journal-title":"Diabetes"},{"key":"2026021723130391000_zwaf444-B27","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification","volume":"356","author":"Manson","year":"2007","journal-title":"N Engl J Med"},{"key":"2026021723130391000_zwaf444-B28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/08820139.2018.1480034","article-title":"Interleukin-6 as a predictor of the risk of cardiovascular disease: a meta-analysis of prospective epidemiological studies","volume":"47","author":"Zhang","year":"2018","journal-title":"Immunol Invest"},{"key":"2026021723130391000_zwaf444-B29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","article-title":"Inflammation, aging, and cardiovascular disease: JACC review topic of the week","volume":"79","author":"Liberale","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026021723130391000_zwaf444-B30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-017-0112-5","article-title":"Ageing: from inflammation to cancer","volume":"15","author":"Leonardi","year":"2018","journal-title":"Immun Ageing"},{"key":"2026021723130391000_zwaf444-B31","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"key":"2026021723130391000_zwaf444-B32","doi-asserted-by":"crossref","first-page":"e1003444","DOI":"10.1371\/journal.pgen.1003444","article-title":"Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases","volume":"9","author":"Ferreira","year":"2013","journal-title":"PLoS Genet"},{"key":"2026021723130391000_zwaf444-B33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jamacardio.2018.2287","article-title":"Association of interleukin 6 receptor variant with cardiovascular disease effects of interleukin 6 receptor blocking therapy: a phenome-wide association study","volume":"3","author":"Cai","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026021723130391000_zwaf444-B34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.123.066213","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among 13","volume":"149","author":"Ridker","year":"2024","journal-title":"Circulation"},{"key":"2026021723130391000_zwaf444-B35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"2026021723130391000_zwaf444-B36","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"The Lancet"},{"key":"2026021723130391000_zwaf444-B37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with COVID-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021723130391000_zwaf444-B38","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2026021723130391000_zwaf444-B39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijid.2020.12.073","article-title":"Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study","volume":"104","author":"Generali","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2026021723130391000_zwaf444-B40","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19","volume":"384","author":"REMAP-CAP Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021723130391000_zwaf444-B41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"key":"2026021723130391000_zwaf444-B42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"key":"2026021723130391000_zwaf444-B43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2013.02.028","article-title":"Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis","volume":"228","author":"van Diepen","year":"2013","journal-title":"Atherosclerosis"},{"key":"2026021723130391000_zwaf444-B44","volume-title":"Endotext","author":"Feingold","year":"2000","edition":"eds"},{"key":"2026021723130391000_zwaf444-B45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Thematic review series: the pathogenesis of atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host1","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"2026021723130391000_zwaf444-B46","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2026021723130391000_zwaf444-B47","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1194\/jlr.P900063-JLR200","article-title":"Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella","volume":"50","author":"Apostolou","year":"2009","journal-title":"J Lipid Res"},{"key":"2026021723130391000_zwaf444-B48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.atherosclerosis.2010.06.006","article-title":"Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes","volume":"212","author":"Apostolou","year":"2010","journal-title":"Atherosclerosis"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf444\/63790685\/zwaf444.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/3\/381\/63790685\/zwaf444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/3\/381\/63790685\/zwaf444.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T04:13:15Z","timestamp":1771387995000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/33\/3\/381\/8205663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,17]]},"published-print":{"date-parts":[[2026,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf444","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,7,17]]}}}